Canada Life’s Geron GERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $126K | Buy |
84,773
+9,613
| +13% | +$14.6K | ﹤0.01% | 1662 |
|
|
2025
Q4 | $99K | Sell |
75,160
-79,832
| -52% | -$100K | ﹤0.01% | 1717 |
|
|
2025
Q3 | $201K | Buy |
154,992
+2,541
| +2% | +$3.38K | ﹤0.01% | 1690 |
|
|
2025
Q2 | $214K | Buy |
152,451
+2,153
| +1% | +$3.05K | ﹤0.01% | 1699 |
|
|
2025
Q1 | $240K | Buy |
150,298
+6,300
| +4% | +$15.3K | ﹤0.01% | 1706 |
|
|
2024
Q4 | $508K | Sell |
143,998
-10,425
| -7% | -$41.6K | ﹤0.01% | 1637 |
|
|
2024
Q3 | $699K | Buy |
154,423
+7,143
| +5% | +$32.5K | ﹤0.01% | 1610 |
|
|
2024
Q2 | $624K | Buy |
147,280
+82,842
| +129% | +$323K | ﹤0.01% | 1626 |
|
|
2024
Q1 | $212K | Buy |
64,438
+7,034
| +12% | +$15.8K | ﹤0.01% | 1823 |
|
|
2023
Q4 | $120K | Sell |
57,404
-4,020
| -7% | -$7.82K | ﹤0.01% | 1907 |
|
|
2023
Q3 | $130K | Buy |
61,424
+27,800
| +83% | +$75.4K | ﹤0.01% | 1917 |
|
|
2023
Q2 | $109K | Sell |
33,624
-1,390
| -4% | -$3.96K | ﹤0.01% | 1916 |
|
|
2023
Q1 | $76K | Buy |
35,014
+6,956
| +25% | +$19.8K | ﹤0.01% | 2012 |
|
|
2022
Q4 | $68K | Sell |
28,058
-1,050
| -4% | -$2.35K | ﹤0.01% | 2040 |
|
|
2022
Q3 | $68K | Buy |
29,108
+11,672
| +67% | +$26.1K | ﹤0.01% | 2053 |
|
|
2022
Q2 | $27K | Buy |
17,436
+368
| +2% | +$520 | ﹤0.01% | 2203 |
|
|
2022
Q1 | $24K | Buy |
17,068
+4,042
| +31% | +$4.51K | ﹤0.01% | 2320 |
|
|
2021
Q4 | $16K | Buy |
13,026
+3,834
| +42% | +$5.49K | ﹤0.01% | 2412 |
|
|
2021
Q3 | $13K | Hold |
9,192
| – | – | ﹤0.01% | 2488 |
|
|
2021
Q2 | $13K | Sell |
9,192
-17,332
| -65% | -$25.2K | ﹤0.01% | 2529 |
|
|
2021
Q1 | $41K | Hold |
26,524
| – | – | ﹤0.01% | 2350 |
|
|
2020
Q4 | $42K | Hold |
26,524
| – | – | ﹤0.01% | 2345 |
|
|
2020
Q3 | $46K | Hold |
26,524
| – | – | ﹤0.01% | 2201 |
|
|
2020
Q2 | $57K | Buy |
26,524
+19,574
| +282% | +$29.3K | ﹤0.01% | 2186 |
|
|
2020
Q1 | $8K | Hold |
6,950
| – | – | ﹤0.01% | 2529 |
|
|
2019
Q4 | $9K | Buy |
+6,950
| New | +$10K | ﹤0.01% | 2584 |
|
|
2019
Q3 | – | Sell |
-13,098
| Closed | -$18K | – | 1572 |
|
|
2019
Q2 | $18K | Hold |
13,098
| – | – | ﹤0.01% | 2592 |
|
|
2019
Q1 | $22K | Hold |
13,098
| – | – | ﹤0.01% | 2365 |
|
|
2018
Q4 | $13K | Hold |
13,098
| – | – | ﹤0.01% | 2565 |
|
|
2018
Q3 | $23K | Hold |
13,098
| – | – | ﹤0.01% | 2493 |
|
|
2018
Q2 | $45K | Hold |
13,098
| – | – | ﹤0.01% | 2424 |
|
|
2018
Q1 | $56K | Hold |
13,098
| – | – | ﹤0.01% | 2337 |
|
|
2017
Q4 | $24K | Hold |
13,098
| – | – | ﹤0.01% | 2482 |
|
|
2017
Q3 | $29K | Hold |
13,098
| – | – | ﹤0.01% | 2441 |
|
|
2017
Q2 | $36K | Hold |
13,098
| – | – | ﹤0.01% | 2409 |
|
|
2017
Q1 | $30K | Hold |
13,098
| – | – | ﹤0.01% | 2408 |
|
|
2016
Q4 | $27K | Hold |
13,098
| – | – | ﹤0.01% | 2449 |
|
|
2016
Q3 | $30K | Hold |
13,098
| – | – | ﹤0.01% | 2430 |
|
|
2016
Q2 | $35K | Hold |
13,098
| – | – | ﹤0.01% | 2391 |
|
|
2016
Q1 | $38K | Hold |
13,098
| – | – | ﹤0.01% | 2215 |
|
|
2015
Q4 | $63K | Hold |
13,098
| – | – | ﹤0.01% | 2043 |
|
|
2015
Q3 | $36K | Hold |
13,098
| – | – | ﹤0.01% | 2204 |
|
|
2015
Q2 | $56K | Buy |
+13,098
| New | +$51.9K | ﹤0.01% | 2155 |
|
Other funds holding GERN
RCM
SCM
DTC
VCM
EP
Canada Life's GERN Position: Q1 2026 in Review
Canada Life increased its Geron (GERN) stake by 13% in Q1 2026, buying an estimated $14.6K and bringing the position to 84,773 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1662.
Canada Life first reported a position in GERN in Q2 2015 and has held it in 43 quarters since. The position peaked at $699K in Q3 2024. 256 funds tracked by Wall St. Rank hold GERN as of Q1 2026.
- Canada Life held 84,773 shares of Geron worth $126K as of Q1 2026.
- Canada Life bought 9,613 Geron shares in Q1 2026, an estimated $14.6K.
- Geron made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1662 holding.
- Canada Life first reported a position in Geron in Q2 2015 and has held it in 43 quarters since.
- Canada Life's Geron position peaked at $699K in Q3 2024.
- 256 funds tracked by Wall St. Rank held Geron as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.